1.58
Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
54.23%
36.53
|
23.68 | 36.12 | 34.66 | 34.99 |
| Operating Income/Loss |
54.23%
-36.53
|
-23.68 | -36.12 | -34.66 | 74.18 |
| Nonoperating Income/Loss |
3.04%
1.977
|
2.039 | 1.702 | 2.123 | 2.384 |
| Net Income/Loss |
59.62%
-34.55
|
-21.64 | -34.42 | -32.54 | 76.56 |
| Basic Average Shares |
6.36%
205.78
|
193.47 | 86.46 | 86.24 | 86.02 |
| Diluted Average Shares |
6.36%
205.78
|
193.47 | 86.46 | 86.24 | 86.10 |
| Basic Earnings Per Share |
54.55%
-0.17
|
-0.11 | -0.40 | -0.38 | 0.89 |
| Diluted Earnings Per Share |
54.55%
-0.17
|
-0.11 | -0.40 | -0.38 | 0.89 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):